WebCitius Pharma (CTXR) Earnings Dates & Reports - Investing.com. 💎 Reveal Undervalued Stocks Hiding in Any Market Get Started. WebApr 2, 2024 · Citius Pharmaceuticals ( NASDAQ:CTXR – Get Rating) last released its earnings results on Friday, February 10th. The company reported ($0.04) earnings per share for the quarter. Citius Pharmaceuticals Price Performance NASDAQ CTXR opened at $1.17 on Friday. The firm has a market cap of $171.12 million, a P/E ratio of -6.50 and a …
Citius Pharma (CTXR) Earnings Dates & Reports - Investing.com
WebAug 8, 2024 · It turns out an average annual growth rate of 75% is expected, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts... WebFind the latest Earnings Report Date for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. sly fox movie club
Citius Pharma Stock (NASDAQ:CTXR), Earnings Estimates, EPS, …
WebApr 10, 2024 · Earnings and Valuation. Earnings Growth. Earnings for Doximity are expected to grow by 21.15% in the coming year, from $0.52 to $0.63 per share. Price to Earnings Ratio vs. the Market. The P/E ratio of Doximity is 64.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.05. WebApr 4, 2024 · Key Expected Earnings Data Earnings Summary For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.04 per share. This reflects a … WebApr 9, 2024 · Traders on the floor of the NYSE, July 12, 2024. U.S equity futures rose slightly Sunday evening as investors looked ahead to key inflation data and the start of first-quarter earnings season ... sly fox nas